Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.
- DOI
- 10.1016/s2665-9913(24)00099-7
- Published
- 2024 Aug
- Container
- The Lancet. Rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2665-9913-24-00099-7,
title = {Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.},
author = {Worth C and Al-Mossawi MH and Macdonald J and Fisher BA and Chan A and Sengupta R and Packham J and Gaffney K and Gullick N and Cook JA and Corn TH and Teh J and Machado PM and Taylor PC and Bowness P},
year = {2024},
journal = {The Lancet. Rheumatology},
doi = {10.1016/s2665-9913(24)00099-7},
url = {https://doi.org/10.1016/s2665-9913(24)00099-7}
}RIS
TY - JOUR TI - Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial. AU - Worth C AU - Al-Mossawi MH AU - Macdonald J AU - Fisher BA AU - Chan A AU - Sengupta R AU - Packham J AU - Gaffney K AU - Gullick N AU - Cook JA AU - Corn TH AU - Teh J AU - Machado PM AU - Taylor PC AU - Bowness P PY - 2024 JO - The Lancet. Rheumatology DO - 10.1016/s2665-9913(24)00099-7 UR - https://doi.org/10.1016/s2665-9913(24)00099-7 ER -
APA
C, W., MH, A., J, M., BA, F., A, C., R, S., J, P., K, G., N, G., JA, C., TH, C., J, T., PM, M., PC, T., & P, B. (2024). Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(24)00099-7
Source records
- pubmed · retrieved 2026-09-26T10:16:09.396Z